202 related articles for article (PubMed ID: 25008344)
61. Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin.
Hanioka N; Ozawa S; Jinno H; Ando M; Saito Y; Sawada J
Xenobiotica; 2001 Oct; 31(10):687-99. PubMed ID: 11695848
[TBL] [Abstract][Full Text] [Related]
62. Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells.
de Castro WV; Mertens-Talcott S; Derendorf H; Butterweck V
J Pharm Sci; 2007 Oct; 96(10):2808-17. PubMed ID: 17542018
[TBL] [Abstract][Full Text] [Related]
63. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components.
Eagling VA; Profit L; Back DJ
Br J Clin Pharmacol; 1999 Oct; 48(4):543-52. PubMed ID: 10583025
[TBL] [Abstract][Full Text] [Related]
64. Red wine and component flavonoids inhibit UGT2B17 in vitro.
Jenkinson C; Petroczi A; Naughton DP
Nutr J; 2012 Sep; 11():67. PubMed ID: 22958586
[TBL] [Abstract][Full Text] [Related]
65. Regioselective glucuronidation of daidzein in liver and intestinal microsomes of humans, monkeys, rats, and mice.
Hanioka N; Ohkawara S; Isobe T; Ochi S; Tanaka-Kagawa T; Jinno H
Arch Toxicol; 2018 Sep; 92(9):2809-2817. PubMed ID: 30014295
[TBL] [Abstract][Full Text] [Related]
66. The inhibition of UDP-glucuronosyltransferases (UGTs) by vitamin A.
Liu X; Cao YF; Dong PP; Zhu LL; Zhao Z; Wu X; Fu ZW; Huang CT; Fang ZZ; Sun HZ
Xenobiotica; 2017 May; 47(5):376-381. PubMed ID: 27359323
[TBL] [Abstract][Full Text] [Related]
67. Evaluation of the in vitro/in vivo drug interaction potential of BST204, a purified dry extract of ginseng, and its four bioactive ginsenosides through cytochrome P450 inhibition/induction and UDP-glucuronosyltransferase inhibition.
Zheng YF; Bae SH; Choi EJ; Park JB; Kim SO; Jang MJ; Park GH; Shin WG; Oh E; Bae SK
Food Chem Toxicol; 2014 Jun; 68():117-27. PubMed ID: 24632066
[TBL] [Abstract][Full Text] [Related]
68. Grapefruit juice and drug interactions. Exploring mechanisms of this interaction and potential toxicity for certain drugs.
Bressler R
Geriatrics; 2006 Nov; 61(11):12-8. PubMed ID: 17112309
[TBL] [Abstract][Full Text] [Related]
69. Regioselective glucuronidation of oxyresveratrol, a natural hydroxystilbene, by human liver and intestinal microsomes and recombinant UGTs.
Hu N; Mei M; Ruan J; Wu W; Wang Y; Yan R
Drug Metab Pharmacokinet; 2014; 29(3):229-36. PubMed ID: 24256624
[TBL] [Abstract][Full Text] [Related]
70. Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4, 5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved.
Nowell SA; Massengill JS; Williams S; Radominska-Pandya A; Tephly TR; Cheng Z; Strassburg CP; Tukey RH; MacLeod SL; Lang NP; Kadlubar FF
Carcinogenesis; 1999 Jun; 20(6):1107-14. PubMed ID: 10357796
[TBL] [Abstract][Full Text] [Related]
71. Inhibitory effect of anthocyanidins on hepatic glutathione S-transferase, UDP-glucuronosyltransferase and carbonyl reductase activities in rat and human.
Szotáková B; Bártíková H; Hlaváčová J; Boušová I; Skálová L
Xenobiotica; 2013 Aug; 43(8):679-85. PubMed ID: 23320385
[TBL] [Abstract][Full Text] [Related]
72. Relative importance of intestinal and hepatic glucuronidation-impact on the prediction of drug clearance.
Cubitt HE; Houston JB; Galetin A
Pharm Res; 2009 May; 26(5):1073-83. PubMed ID: 19184618
[TBL] [Abstract][Full Text] [Related]
73. Inhibition of UDP-glucuronosyltransferase (UGT)-mediated glycyrrhetinic acid 3-O-glucuronidation by polyphenols and triterpenoids.
Koyama M; Shirahata T; Hirashima R; Kobayashi Y; Itoh T; Fujiwara R
Drug Metab Pharmacokinet; 2017 Aug; 32(4):218-223. PubMed ID: 28754329
[TBL] [Abstract][Full Text] [Related]
74. In vitro glucuronidation of the primary metabolite of 10-chloromethyl-11-demethyl-12-oxo-calanolide A by human liver microsomes and its interactions with UDP-glucuronosyltransferase substrates.
Liu X; Sheng L; Zhao M; Mi J; Liu Z; Li Y
Drug Metab Pharmacokinet; 2015 Feb; 30(1):89-96. PubMed ID: 25760535
[TBL] [Abstract][Full Text] [Related]
75. Drug-drug interactions of silymarin on the perspective of pharmacokinetics.
Wu JW; Lin LC; Tsai TH
J Ethnopharmacol; 2009 Jan; 121(2):185-93. PubMed ID: 19041708
[TBL] [Abstract][Full Text] [Related]
76. Determination of the kinetics of rat UDP-glucuronosyltransferases (UGTs) in liver and intestine using HPLC.
Narayanan R; LeDuc B; Williams DA
J Pharm Biomed Anal; 2000 Apr; 22(3):527-40. PubMed ID: 10766370
[TBL] [Abstract][Full Text] [Related]
77. Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.
Schmiedlin-Ren P; Edwards DJ; Fitzsimmons ME; He K; Lown KS; Woster PM; Rahman A; Thummel KE; Fisher JM; Hollenberg PF; Watkins PB
Drug Metab Dispos; 1997 Nov; 25(11):1228-33. PubMed ID: 9351897
[TBL] [Abstract][Full Text] [Related]
78. Development of an assay using 4-trifluoromethylumbelliferyl as a marker substrate for assessment of drug-drug interactions to multiple isoforms of UDP-glucuronosyltransferases.
Baranczewski P; Kallin A; Andersson A; Hagigi S; Aberg M; Postlind H; Mankowitz L
Assay Drug Dev Technol; 2004 Aug; 2(4):345-52. PubMed ID: 15357915
[TBL] [Abstract][Full Text] [Related]
79. Tacrolimus strongly inhibits multiple human UDP-glucuronosyltransferase (UGT) isoforms.
Liu XY; Fang ZZ; Dong PP; Shi XH; Teng YJ; Sun XY
Pharmazie; 2012 Sep; 67(9):804-8. PubMed ID: 23016456
[TBL] [Abstract][Full Text] [Related]
80. In vitro inhibition of UGT1A3, UGT1A4 by ursolic acid and oleanolic acid and drug-drug interaction risk prediction.
Xie H; Wu J; Liu D; Liu M; Zhang H; Huang S; Xiong Y; Xia C
Xenobiotica; 2017 Sep; 47(9):785-792. PubMed ID: 27600106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
